179 related articles for article (PubMed ID: 18510989)
1. Management of venous thromboembolism in patients with advanced cancer: a systematic review and meta-analysis.
Noble SI; Shelley MD; Coles B; Williams SM; Wilcock A; Johnson MJ;
Lancet Oncol; 2008 Jun; 9(6):577-84. PubMed ID: 18510989
[TBL] [Abstract][Full Text] [Related]
2. Venous thromboembolism in cancer patients.
Deng A; Galanis T; Graham MG
Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
[TBL] [Abstract][Full Text] [Related]
3. Long-term prophylaxis in venous thromboembolism: LMWH or oral anticoagulation?
Schulman S
Haemostasis; 1998; 28 Suppl 3():17-21. PubMed ID: 10069758
[TBL] [Abstract][Full Text] [Related]
4. The prevention and treatment of venous thromboembolism with LMWHs and new anticoagulants.
Blann AD; Khoo CW
Vasc Health Risk Manag; 2009; 5():693-704. PubMed ID: 19707288
[TBL] [Abstract][Full Text] [Related]
5. A review of the practical advantages of low molecular weight heparin in the treatment of cancer-related venous thromboembolism.
Rhodes S; Bond S
Eur J Oncol Nurs; 2008 Dec; 12(5):425-9. PubMed ID: 18842458
[TBL] [Abstract][Full Text] [Related]
6. European guidelines on perioperative venous thromboembolism prophylaxis: Surgery in the obese patient.
Venclauskas L; Maleckas A; Arcelus JI;
Eur J Anaesthesiol; 2018 Feb; 35(2):147-153. PubMed ID: 29112546
[TBL] [Abstract][Full Text] [Related]
7. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
[TBL] [Abstract][Full Text] [Related]
8. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
9. Long-term use of different doses of low-molecular-weight heparin versus vitamin K antagonists in the treatment of venous thromboembolism.
Romera-Villegas A; Cairols-Castellote MA; Vila-Coll R; Martí-Mestre X; Colomé E; Iguaz I
Ann Vasc Surg; 2010 Jul; 24(5):628-39. PubMed ID: 19932949
[TBL] [Abstract][Full Text] [Related]
10. Anticoagulation and bleeding: a pooled analysis of lung cancer trials of the NCIC Clinical Trials Group.
Le Maître A; Ding K; Shepherd FA; Leighl N; Arnold A; Seymour L;
J Thorac Oncol; 2009 May; 4(5):586-94. PubMed ID: 19357539
[TBL] [Abstract][Full Text] [Related]
11. Perioperative anticoagulant management.
Grant PJ; Brotman DJ; Jaffer AK
Med Clin North Am; 2009 Sep; 93(5):1105-21. PubMed ID: 19665623
[TBL] [Abstract][Full Text] [Related]
12. Prevention and Treatment of Venous Thromboembolism in Patients with Cancer: Focus on Drug Therapy.
van Es N; Bleker SM; Wilts IT; Porreca E; Di Nisio M
Drugs; 2016 Mar; 76(3):331-41. PubMed ID: 26729187
[TBL] [Abstract][Full Text] [Related]
13. Low-molecular-weight heparin versus warfarin for secondary prophylaxis of venous thromboembolism: a cost-effectiveness analysis.
Marchetti M; Pistorio A; Barone M; Serafini S; Barosi G
Am J Med; 2001 Aug; 111(2):130-9. PubMed ID: 11498067
[TBL] [Abstract][Full Text] [Related]
14. Long-term anticoagulation treatment for acute venous thromboembolism in patients with and without cancer. The SWIss Venous ThromboEmbolism Registry (SWIVTER) II.
Spirk D; Ugi J; Korte W; Husmann M; Hayoz D; Baldi T; Frauchiger B; Banyai M; Aujesky D; Baumgartner I; Kucher N
Thromb Haemost; 2011 Jun; 105(6):962-7. PubMed ID: 21475778
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis, prevalence, and management of thromboembolism in patients with spinal cord injury.
Green D
J Spinal Cord Med; 2003; 26(4):329-34. PubMed ID: 14992332
[TBL] [Abstract][Full Text] [Related]
16. Management of cancer-associated thrombosis in people with advanced disease.
Noble S; Johnson MJ
BMJ Support Palliat Care; 2012 Jun; 2(2):163-7. PubMed ID: 24654059
[TBL] [Abstract][Full Text] [Related]
17. Acute phase treatment of VTE: Anticoagulation, including non-vitamin K antagonist oral anticoagulants.
Hillis C; Crowther MA
Thromb Haemost; 2015 Jun; 113(6):1193-202. PubMed ID: 25948149
[TBL] [Abstract][Full Text] [Related]
18. Use of Direct Oral Anticoagulants for Treating Venous Thromboembolism in Patients With Cancer.
Soff GA
J Natl Compr Canc Netw; 2018 May; 16(5S):670-673. PubMed ID: 29784753
[TBL] [Abstract][Full Text] [Related]
19. Incidence of venous thromboembolism and hemorrhage related safety studies of preoperative anticoagulation therapy in hip fracture patients undergoing surgical treatment: a case-control study.
Liu Z; Han N; Xu H; Fu Z; Zhang D; Wang T; Jiang B
BMC Musculoskelet Disord; 2016 Feb; 17():76. PubMed ID: 26873584
[TBL] [Abstract][Full Text] [Related]
20. Treatment of venous thromboembolism.
Wells PS; Forgie MA; Rodger MA
JAMA; 2014 Feb; 311(7):717-28. PubMed ID: 24549552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
